Please login to the form below

Not currently logged in

J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company

The company has also appointed Paul Ruh as its chief financial officer designate

Thibaut Mongon

Johnson & Johnson (J&J) has announced the appointment of Thibaut Mongon as chief executive officer (CEO) designate and Paul Ruh as chief financial officer (CFO) designate of the New Consumer Health Company.

Planned since November 2021, J&J will separate into two companies – the new Johnson & Johnson and the New Consumer Health Company.

By doing this, the companies believe they will be better able to provide improved health outcomes for patients and consumers through innovation, and that the separation will allow for the pursuit of more targeted business strategies and accelerated growth.

This leadership change is expected to occur in 2023, once the planned separation of the Consumer Health business has been finalised, subject to legal requirements.

Thibaut Mongon has over 20 years’ global experience at J&J, having been executive vice president and worldwide chairman of consumer health at the company since 2019. He is also currently on the board of the Consumer Goods Forum.

His experience in the industry includes leading one of the world’s largest portfolios of consumer health products with trusted brands including Tylenol, Neutrogena, Aveeno, Listerine, and Johnson’s.

Paul Ruh has a wealth of experience in executive global finances, with specific experience in the consumer-packaged goods industry. Prior to joining J&J five years ago, Ruh worked as CFO of PepsiCo Latin America from 2015 to 2017, as part of his 17-year tenure at the company. He also held earlier positions at McKinsey and Procter & Gamble.

Commenting on the new appointments, Joaquin Duato, CEO of J&J, said: “With Thibaut at the helm, we can expect the New Consumer Health Company to remain mission driven with iconic, science-backed brands and a strong commitment to innovation and remarkable talent.

“He will be supported by Paul, who brings a strong track record of delivering transformational improvements and who has in-depth knowledge and expertise of the consumer goods industry. I am confident that Thibaut and Paul are the right leaders to deliver significant value for stakeholders.”

Article by
Fleur Jeffries

17th May 2022

From: Marketing, Healthcare



Subscribe to our email news alerts


Add my company
Research Partnership

Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....